Sign In to Follow Application
View All Documents & Correspondence

A Composition Comprising Mangiferin, And Beta D Glucan And Uses Thereof

Abstract: The present disclosure provides a composition comprising of mangiferin, and beta-D-glucan, which at particular w/w ratios exhibits synergistic inhibition of intracellular reactive oxygen species production. Also provided in the present disclosure methods of inhibiting intracellular reactive oxygen species production.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
22 January 2015
Publication Number
31/2016
Publication Type
INA
Invention Field
PHARMACEUTICALS
Status
Email
lsmds@lakshmisri.com
Parent Application

Applicants

ITC LIMITED
ITC LIFE SCIENCES AND TECHNOLOGY CENTRE #3, 1st Main, Peenya Industrial Area, Phase 1, Bangalore 560 058

Inventors

1. RADHAKRISHNAN, Yashwanth
ITC Life Sciences And Technology Centre #3. 1st Main, Peenya Industrial area, Phase-1, Bangalore 560 058
2. SHETTY, Shilpa Sachin
ITC Life Sciences And Technology Centre #3. 1st Main, Peenya Industrial area, Phase-1, Bangalore 560 058
3. DEVAN, Sabarinathan
ITC Life Sciences And Technology Centre #3. 1st Main, Peenya Industrial area, Phase-1, Bangalore 560 058
4. KS, Nandakumar
ITC Life Sciences And Technology Centre #3. 1st Main, Peenya Industrial area, Phase-1, Bangalore 560 058
5. CHITTUR, Lakshmanan Chandrasekharan
ITC Life Sciences And Technology Centre #3. 1st Main, Peenya Industrial area, Phase-1, Bangalore 560 058

Specification

CLIAMS:1. A composition for inhibiting intracellular reactive oxygen species production, said composition comprising:
a. mangiferin; and
b. beta-D-glucan.
2. The composition as claimed in claim 1, wherein mangiferin to beta-D-glucan w/w ratio in said composition is 0.8:1-1.3:1.
3. The composition as claimed in claim 1, optionally comprising of suitable carriers, diluents, and excipients.
4. A method of inhibiting intracellular reactive oxygen species production, said method comprising:
a. obtaining a composition as claimed in claim 1; and
b. contacting said composition with a cell capable of reactive oxygen species production,
wherein said method inhibits intracellular reactive oxygen species production in said cell.
5. A method of preparing a composition as claimed in claim 1.
6. Use of a composition as claimed in claim 1 in inhibiting intracellular reactive oxygen species production.
,TagSPECI:As Attached

Documents

Application Documents

# Name Date
1 PD014941IN-SC SPEC FOR FILING.pdf 2015-03-12
2 PD014941IN-SC FORM 5.pdf 2015-03-12
3 PD014941IN-SC FORM 3.pdf 2015-03-12
4 PD014941IN-SC FIGURES FOR FILING.pdf 2015-03-12
5 308-CHE-2015 POWER OF ATTORNEY 01-05-2015.pdf 2015-05-01
6 308-CHE-2015 FORM-1 01-05-2015.pdf 2015-05-01
7 308-CHE-2015 CORRESPONDENCE OTHERS 01-05-2015.pdf 2015-05-01
8 308-CHE-2015-FORM 18 [04-12-2018(online)].pdf 2018-12-04
9 308-CHE-2015-FER.pdf 2020-01-29

Search Strategy

1 2020-01-2218-31-56_22-01-2020.pdf